Results 41 to 50 of about 485 (131)

In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development [PDF]

open access: yesFrontiers in Immunology, 2017
Molecular engineering to increase the percentage identity to common human immunoglobulin sequences of non-human therapeutic antibodies and scaffolds has become standard practice.
John Steven   +11 more
doaj   +4 more sources

Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern [PDF]

open access: yesInternational Journal of Molecular Sciences, 2022
Blanca J Valdovino-Navarro   +2 more
exaly   +2 more sources

vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target. [PDF]

open access: yesAntibodies (Basel)
Glioblastoma is the most prevalent and fatal form of primary brain tumors. New targeted therapeutic strategies for this type of tumor are imperative given the dire prognosis for glioblastoma patients and the poor results of current multimodal therapy.
Manzanares-Guzmán A   +2 more
europepmc   +4 more sources

Yeast Surface Dual Display Platform for Rapid Discovery of Shark VNAR from a Semi-Synthetic Library Followed by Next-Generation Sequencing

open access: yesApplied Sciences, 2023
The shark-derived single-domain antibody VNAR (variable domain of new antigen receptor) has many advantageous features that make the VNAR suitable for improving current monoclonal antibody therapy deficiencies or disease diagnosis methods.
Chia-Hung Tsai   +3 more
doaj   +1 more source

Shark-derived single-domain antibodies for the detection of decapod iridescent virus 1

open access: yesAquaculture Reports, 2023
Decapod iridescent virus 1 (DIV1) has emerged as a novel threat to shrimp farming. The development of a rapid, convenient, and accurate method for diagnosing DIV1 is urgently needed, serving as a key factor in the reduction of the risk of viral outbreaks.
Jinlin Chen   +6 more
doaj   +1 more source

A Class of Shark‐Derived Single‐Domain Antibodies can Broadly Neutralize SARS‐Related Coronaviruses and the Structural Basis of Neutralization and Omicron Escape

open access: yesSmall Methods, Volume 6, Issue 7, July 20, 2022., 2022
Shark‐derived vnarbodies 20G6 and 17F6 broadly neutralize SARS‐CoV‐2 Wuhan, Alpha, Beta, Kappa, Delta, Delta‐plus, Lambda variants, and sarbecovirus coronaviruses, but are unexpectedly ineffective for Omicron. Intranasal administration of 20G6 confers effective preventive and therapeutic effects in mice infected with SARS‐CoV‐2 Wuhan and Beta variant ...
Bo Feng   +21 more
wiley   +1 more source

Detection of genome‐edited and endogenously expressed G protein‐coupled receptors

open access: yesThe FEBS Journal, Volume 288, Issue 8, Page 2585-2601, April 2021., 2021
G protein‐coupled receptors (GPCRs) are the largest family of membrane receptors and major targets for FDA‐approved drugs. Quantifying GPCR expression and ligand binding characteristics in different cell types is important for drug discovery. The advent of genome editing and developments in fluorescent ligand design offers exciting possibilities to ...
Mark Soave   +6 more
wiley   +1 more source

Functionalization of polymeric nanoparticles with targeting VNAR ligands using vinyl sulfone conjugation

open access: yesJournal of Materials Chemistry B, 2023
Vinyl sulfone (VS) functionalization – An innovative conjugation approach for preparation of variable new antigen receptor (VNAR) targeted polymeric nanoparticles.
Adam Leach   +9 more
openaire   +4 more sources

Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics

open access: yesFrontiers in Molecular Biosciences, 2021
Sharks and other cartilaginous fish are the phylogenetically oldest living organisms that have antibodies as part of their adaptive immune system.
Monica L. Fernández-Quintero   +3 more
doaj   +1 more source

Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications

open access: yesCells, 2021
Shark is a cartilaginous fish that produces new antigen receptor (IgNAR) antibodies. This antibody is identified with a similar human heavy chain but dissimilar sequences.
Salma Nassor Juma   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy